Title : Gallbladder cancer with EGFR mutation and its response to GemOx with erlotinib: a case report and review of literature.

Pub. Date : 2020 Jul 4

PMID : 32622356






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 CONCLUSION: This case reports the possible efficacy of erlotinib in combination with gemcitabine and oxaliplatin in treating an EGFR-mutated GBC with liver metastasis. gemcitabine epidermal growth factor receptor Homo sapiens